Exhibit 99.1

                                                                COMPANY CONTACT:
                                        Steve P. Loomis, Chief Financial Officer
                                                                sloomis@cdic.com
                                                          800-778-4825 Ext. 1015

              CardioDynamics Regains Compliance with NASDAQ Listing
                                  Requirements

SAN DIEGO, CA--May 27, 2008--CardioDynamics International Corporation (Nasdaq:
CDICD), the innovator and leader of impedance cardiography (ICG) technology,
today announced that it has regained compliance with Nasdaq listing
requirements. On May 23, 2008, the Company received notification from Nasdaq
that it is once again in compliance with the $1.00 minimum bid price requirement
set forth in Nasdaq Marketplace Rule 4310(c)(4) and that the Company's
non-compliance announced on April 18, 2008, has been remedied.

Michael K. Perry, CardioDynamics Chief Executive Officer, stated, "We are
pleased to regain compliance with the Nasdaq listing requirements and have the
immediate threat of delisting now clearly behind us. Investor response has been
favorable to the reverse split with our share price advancing during challenging
market conditions. We believe the reinstated Nasdaq compliance coupled with our
recent five consecutive quarters of revenue growth, international sales
momentum, continued growth plan for 2008, and intense focus on achieving
positive operating cash flow by the fourth quarter are solid catalysts for
growth in shareholder value."

About CardioDynamics:

CardioDynamics, the ICG Company, is the innovator and leader of an important
medical technology called impedance cardiography. The Company develops,
manufactures and markets noninvasive diagnostic and monitoring technologies and
medical device electrodes. The Company's ICG Systems are being used by
physicians around the world to help battle the number one killer of men and
women--cardiovascular disease. Partners include GE Healthcare, Philips Medical
Systems and Mindray. For additional information, please refer to the company's
Web site at www.cdic.com.

Forward-Looking (Safe Harbor) Statement:
Except for historical and factual information contained herein, this press
release contains forward-looking statements, such as those relating to the
company's ability to maintain compliance with Nasdaq listing standards, future
growth and positive operating cash flows, the accuracy of which is necessarily
subject to uncertainties and risks including the Company's primary dependence on
the BioZ product line, and various uncertainties characteristic of early growth
companies, as well as other risks detailed in the Company's filings with the
SEC, including its 2007 Form 10-K. The Company does not undertake to update the
disclosures contained in this press release.